Symptomatic Treatment for Viral and Bacterial Sinusitis

Distinguishing Viral from Bacterial Sinusitis

The American Academy of Otolaryngology-Head and Neck Surgery recommends distinguishing between viral rhinosinusitis (VRS) and acute bacterial rhinosinusitis (ABRS) based on symptoms lasting less than 10 days with gradual improvement for VRS, and persistent symptoms, severe symptoms, or double-worsening for ABRS 1, 2
VRS symptoms typically peak within 3 days and resolve within 10-14 days, with no high fever or severe facial pain 2, 3

The American Academy of Otolaryngology-Head and Neck Surgery recommends analgesics (acetaminophen or ibuprofen), nasal saline irrigation, and topical intranasal corticosteroids as first-line symptomatic therapy for both viral and bacterial sinusitis 1, 2
Nasal saline irrigation provides low-risk relief of congestion and facilitates mucus clearance, and can be used multiple times daily 1, 2, 4
Topical intranasal corticosteroids provide modest symptom relief after 15 days of use, with a number needed to treat of 14, and are a reasonable option for both VRS and ABRS 1, 2

For viral rhinosinusitis, provide symptomatic relief with analgesics, saline irrigation, and intranasal steroids, and educate patients that symptoms typically resolve within 10-14 days 1, 2, 4
For acute bacterial rhinosinusitis, consider antibiotic therapy, such as amoxicillin, and continue symptomatic measures, with watchful waiting an option for mild cases 1, 5

For children under 3 years, avoid decongestants and antihistamines, and focus on saline irrigation and analgesics 4
For patients with chronic conditions, such as asthma or COPD, monitor closely for symptom progression and consider earlier intervention if respiratory status deteriorates 4

Instruct patients to return if symptoms worsen or fail to improve within 3-5 days of treatment, or if high fever develops or persists, or if severe headache, facial swelling, or visual changes occur 5, 4, 1

The European Position Paper on Rhinosinusitis (EPOS) guidelines advise against the use of systemic corticosteroids for rhinovirus infections or acute post-viral rhinosinusitis due to lack of benefit on recovery and potential harm 6
Systemic corticosteroids do not improve recovery at 7-14 days in acute post-viral rhinosinusitis 6
The use of systemic corticosteroids has a small effect on facial pain at days 4-7, but this minimal benefit does not justify the potential adverse events 6
Acute post-viral rhinosinusitis (including rhinovirus) is a self-limiting disease that resolves without steroids 6, 7
Intranasal corticosteroids may provide modest symptom relief, though the effect is small 6, 7

Antibiotics should not be prescribed for rhinovirus infections as they are completely ineffective for viral illness and contribute to antimicrobial resistance 7